Regional hemodynamic effects of dopamine in the indomethacin-treated preterm infant

Journal of Perinatology

Volumn 22, Issue 4, 2002, Pages 300-305

  Seri, Istvan ^a   Abbasi, Soraya ^b   Wood, Dennis C ^b   Gerdes, Jeffrey S ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PENNSYLVANIA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; INDOMETACIN;

ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GESTATIONAL AGE; HEART RATE; HEMODYNAMICS; HUMAN; INFANT; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; MALE; MESENTERY BLOOD FLOW; NEWBORN; OLIGURIA; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PULSE RATE; SUPERIOR MESENTERIC ARTERY; TISSUE PERFUSION; URINE VOLUME; VASODILATATION;

BLOOD FLOW VELOCITY; DOPAMINE; DRUG INTERACTIONS; HEMODYNAMIC PROCESSES; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; KIDNEY; PROSPECTIVE STUDIES; PULSATILE FLOW; VASODILATION;

EID: 85047695564     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7210698     Document Type: Article

References (26)

1. Cardiovascular and renal actions of dopamine: Potential clinical applications
2. Cardiovascular, renal, and endocrine actions of dopamine in neonates and children
3. Effect of dopamine on regional blood flows in sick preterm neonates
4. Recommendations for the postnatal use of indomethacin: An analysis of four separate treatment strategies
5. Indomethacin-induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging
6. Effect of indomethacin on superior mesenteric artery blood flow velocity in preterm infants
7. Indomethacin, patent ductus arteriosus, and cerebral blood flow
8. Effects of prophylactic low-dose indomethacin on hemodynamics in very low birth weight infants
9. Indomethacin and renal function in premature infants with persistent patent ductus arteriosus
10. Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus
11. Intravenous indomethacin and changes in renal function in premature infants with patent ductus arteriosus
12. Blood pressure measurements in the newborn
13. Cerebral Doppler studies in the fetus and the newborn infant
14. Impact on blood pressure and intestinal perfusion of dobutamine or dopamine in hypotensive preterm infants
15. The hemodynamic effects of dopamine and volume expansion in sick preterm infants
16. The use of dopamine for the prevention of the renal side effects of indomethacin in premature infants with patent ductus arteriosus
17. Effect of indomethacin vs. indomethacin + dopamine on serum BUN and creatinine, urinary output and the closure of patent ductus arteriosus in preterm neonates with hyaline membrane disease
18. Effect of dopamine on failure of indomethacin to close the patent ductus arteriosus
19. Can dopamine prevent the renal side effects of indomethacin? A prospective randomized clinical study
20. Fetal catecholamine release in preterm delivery
21. Sympathoadrenal activity in preterm infants during the first five days of life
22. Cardiovascular response to dopamine in hypotensive preterm infants with severe hyaline membrane disease
23. Dopamine pharmacokinetics in critically ill newborn infants
24. The effect of low-dose dopamine infusion on cardiopulmonary and renal status in premature newborns with respiratory distress syndrome
25. Effects of low-dose dopamine on cardiovascular and renal functions, cerebral blood flow, and plasma catecholamine levels in sick preterm neonates
26. Circulatory support of the sick preterm infant